These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31432422)

  • 1. Untargeted Metabolomics Relative Quantification by SWATH Mass Spectrometry Applied to Cerebrospinal Fluid.
    Mendes VM; Coelho M; Manadas B
    Methods Mol Biol; 2019; 2044():321-336. PubMed ID: 31432422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWATH Mass Spectrometry Applied to Cerebrospinal Fluid Differential Proteomics: Establishment of a Sample-Specific Method.
    Anjo SI; Santa C; Manadas B
    Methods Mol Biol; 2019; 2044():169-189. PubMed ID: 31432413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptidomic Workflow Applied to Cerebrospinal Fluid Analysis.
    Ziganshin RH; Kovalchuk SI; Azarkin IV
    Methods Mol Biol; 2019; 2044():111-118. PubMed ID: 31432409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of information dependent acquisition mass spectra and sequential window acquisition of all theoretical fragment-ion mass spectra for fruit juices metabolomics and authentication.
    Xu L; Xu Z; Strashnov I; Liao X
    Metabolomics; 2020 Jul; 16(7):81. PubMed ID: 32638130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-extraction for Metabolomics and Proteomics from a Single CSF Sample.
    Hörmann P; Barkovits K; Marcus K; Hiller K
    Methods Mol Biol; 2019; 2044():337-342. PubMed ID: 31432423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Top-Down Proteomics Applied to Human Cerebrospinal Fluid.
    Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M
    Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advancing untargeted metabolomics using data-independent acquisition mass spectrometry technology.
    Wang R; Yin Y; Zhu ZJ
    Anal Bioanal Chem; 2019 Jul; 411(19):4349-4357. PubMed ID: 30847570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of Cerebrospinal Fluid Proteome Variations by Isobaric Labeling Coupled with Strong Cation-Exchange Chromatography and Tandem Mass Spectrometry.
    Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
    Methods Mol Biol; 2019; 2044():155-168. PubMed ID: 31432412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analytical considerations for (un)-targeted metabolomic studies with special focus on forensic applications.
    Boxler MI; Schneider TD; Kraemer T; Steuer AE
    Drug Test Anal; 2019 May; 11(5):678-696. PubMed ID: 30408838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing Cerebrospinal Fluid Proteomes to Characterize Central Nervous System Disorders: A Highly Automated Mass Spectrometry-Based Pipeline for Biomarker Discovery.
    Núñez Galindo A; Macron C; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 1959():89-112. PubMed ID: 30852817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deployment of Label-Free Quantitative Olfactory Proteomics to Detect Cerebrospinal Fluid Biomarker Candidates in Synucleinopathies.
    Lachén-Montes M; González-Morales A; Fernández-Irigoyen J; Santamaría E
    Methods Mol Biol; 2019; 2044():273-289. PubMed ID: 31432419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Versatile Workflow for Cerebrospinal Fluid Proteomic Analysis with Mass Spectrometry: A Matter of Choice between Deep Coverage and Sample Throughput.
    Macron C; Núñez Galindo A; Cominetti O; Dayon L
    Methods Mol Biol; 2019; 2044():129-154. PubMed ID: 31432411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.
    Kennedy AD; Pappan KL; Donti TR; Evans AM; Wulff JE; Miller LAD; Reid Sutton V; Sun Q; Miller MJ; Elsea SH
    Mol Genet Metab; 2017 Jun; 121(2):83-90. PubMed ID: 28412083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative Evaluation of Different Protein Fractions of Cerebrospinal Fluid Using
    Birke R; Krause E; Schümann M; Blasig IE; Haseloff RF
    Methods Mol Biol; 2019; 2044():119-128. PubMed ID: 31432410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of simultaneous targeted metabolite quantification and untargeted metabolomics strategy using dual-column liquid chromatography coupled with tandem mass spectrometry.
    Gao Y; Chen Y; Yue X; He J; Zhang R; Xu J; Zhou Z; Wang Z; Zhang R; Abliz Z
    Anal Chim Acta; 2018 Dec; 1037():369-379. PubMed ID: 30292313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An integrated strategy to improve data acquisition and metabolite identification by time-staggered ion lists in UHPLC/Q-TOF MS-based metabolomics.
    Wang Y; Feng R; He C; Su H; Ma H; Wan JB
    J Pharm Biomed Anal; 2018 Aug; 157():171-179. PubMed ID: 29802989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancing coverage in LC-MS-based untargeted metabolomics by a new sample preparation procedure using mixed-mode solid-phase extraction and two derivatizations.
    Wu Q; Xu Y; Ji H; Wang Y; Zhang Z; Lu H
    Anal Bioanal Chem; 2019 Sep; 411(23):6189-6202. PubMed ID: 31414155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomic spectral libraries for data-independent SWATH liquid chromatography mass spectrometry acquisition.
    Bruderer T; Varesio E; Hidasi AO; Duchoslav E; Burton L; Bonner R; Hopfgartner G
    Anal Bioanal Chem; 2018 Mar; 410(7):1873-1884. PubMed ID: 29411086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing a SWATH capillary LC-MS/MS method for simultaneous therapeutic drug monitoring and untargeted metabolomics analysis of neonatal plasma.
    Xiao J; Shi J; Li R; Her L; Wang X; Li J; Sorensen MJ; Bhatt-Mehta V; Zhu HJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Aug; 1179():122865. PubMed ID: 34365292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.